Revvity (NYSE:RVTY) Shares Gap Down to $100.48

Revvity, Inc. (NYSE:RVTY - Get Free Report)'s share price gapped down before the market opened on Thursday . The stock had previously closed at $100.48, but opened at $97.99. Revvity shares last traded at $98.42, with a volume of 95,283 shares.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Evercore ISI upgraded Revvity from an "in-line" rating to an "outperform" rating and upped their price target for the stock from $88.00 to $125.00 in a research note on Thursday, January 4th. Stifel Nicolaus increased their price objective on Revvity from $95.00 to $110.00 and gave the stock a "hold" rating in a research report on Friday, February 2nd. KeyCorp increased their price objective on Revvity from $110.00 to $126.00 and gave the stock an "overweight" rating in a research report on Friday, February 2nd. UBS Group cut Revvity from a "buy" rating to a "neutral" rating and increased their price objective for the stock from $105.00 to $125.00 in a research report on Tuesday, January 16th. Finally, Barclays increased their price objective on Revvity from $92.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Thursday, January 25th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $118.91.

Revvity Trading Down 1.2 %

The business has a 50 day simple moving average of $104.91 and a 200-day simple moving average of $101.70. The company has a current ratio of 2.07, a quick ratio of 1.77 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $12.27 billion, a price-to-earnings ratio of 18.12, a price-to-earnings-growth ratio of 2.61 and a beta of 1.09.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Thursday, February 1st. The company reported $1.25 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.10. The company had revenue of $695.90 million for the quarter. Revvity had a return on equity of 7.41% and a net margin of 25.20%. On average, equities analysts predict that Revvity, Inc. will post 4.65 earnings per share for the current year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Friday, April 19th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.28%. Revvity's dividend payout ratio (DPR) is 5.09%.

Insider Transactions at Revvity

In other news, insider Prahlad R. Singh sold 21,217 shares of the firm's stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $104.28, for a total value of $2,212,508.76. Following the transaction, the insider now directly owns 92,801 shares in the company, valued at approximately $9,677,288.28. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.60% of the company's stock.

Institutional Investors Weigh In On Revvity

Hedge funds have recently modified their holdings of the stock. Parkside Financial Bank & Trust purchased a new stake in shares of Revvity during the 4th quarter valued at about $25,000. Gladius Capital Management LP increased its holdings in Revvity by 84.1% during the 3rd quarter. Gladius Capital Management LP now owns 232 shares of the company's stock worth $26,000 after purchasing an additional 106 shares during the last quarter. Benjamin F. Edwards & Company Inc. purchased a new stake in Revvity during the 4th quarter worth approximately $27,000. CENTRAL TRUST Co purchased a new stake in Revvity during the 4th quarter worth approximately $27,000. Finally, ORG Partners LLC purchased a new stake in Revvity during the 4th quarter worth approximately $32,000. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.